Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dalbagni

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
The Urologic Clinics of North America|March 4, 2000
Current use and questions concerning intravesical bladder cancer group for superficial bladder cancerG Dalbagni, H W Herr
Seminars in Surgical Oncology|September 1, 1997
Genetic studies and molecular markers of bladder cancerC Cordon-Cardo, J Sheinfeld, G Dalbagni
The Journal of Urology|August 24, 1999
Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?G Dalbagni, T Rechtschaffen, H W Herr
The Journal of Urology|March 19, 1999
Splenosis mimicking transitional cell carcinomaR P Weinstein, E M Genega, G Dalbagni
Urology|January 1, 1994
Clinical follow-up in 24 nonfamilial renal tumors cytogenetically characterized in tissue cultureM Golimbu, G Dalbagni, J Provet, et al.
British Journal of Urology|January 12, 1999
Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategyG Dalbagni, Z F Zhang, L Lacombe, et al.
Surgical Oncology Clinics of North America|April 1, 1995
Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practiceG Dalbagni, C Cordon-Cardo, V Reuter, et al.
The American Surgeon|May 1, 1985
Carcinoma of the pancreas in nonjaundiced patients. A silent diseaseN Sheth, G Dalbagni, R E Rothenberg, et al.
Urology|June 15, 1999
Male urethral carcinoma: analysis of treatment outcomeG Dalbagni, Z F Zhang, L Lacombe, et al.
Annals of Surgical Oncology|April 4, 1998
Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancerB R Kava, G Dalbagni, K C Conlon, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
The Urologic Clinics of North America|March 4, 2000
Current use and questions concerning intravesical bladder cancer group for superficial bladder cancerG Dalbagni, H W Herr
Seminars in Surgical Oncology|September 1, 1997
Genetic studies and molecular markers of bladder cancerC Cordon-Cardo, J Sheinfeld, G Dalbagni
The Journal of Urology|August 24, 1999
Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy?G Dalbagni, T Rechtschaffen, H W Herr
The Journal of Urology|March 19, 1999
Splenosis mimicking transitional cell carcinomaR P Weinstein, E M Genega, G Dalbagni
Urology|January 1, 1994
Clinical follow-up in 24 nonfamilial renal tumors cytogenetically characterized in tissue cultureM Golimbu, G Dalbagni, J Provet, et al.
British Journal of Urology|January 12, 1999
Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategyG Dalbagni, Z F Zhang, L Lacombe, et al.
Surgical Oncology Clinics of North America|April 1, 1995
Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practiceG Dalbagni, C Cordon-Cardo, V Reuter, et al.
The American Surgeon|May 1, 1985
Carcinoma of the pancreas in nonjaundiced patients. A silent diseaseN Sheth, G Dalbagni, R E Rothenberg, et al.
Urology|June 15, 1999
Male urethral carcinoma: analysis of treatment outcomeG Dalbagni, Z F Zhang, L Lacombe, et al.
Annals of Surgical Oncology|April 4, 1998
Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancerB R Kava, G Dalbagni, K C Conlon, et al.
Pageof 5